Indivior Share Price | |
---|---|
Price | 1,694.00 |
Bid | 1,709.00 |
Ask | 1,711.00 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 1,694.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 135.94m |
Market Capitalisation | £2.30b |
Market Size | 1,500 |
52 Week High | 1,927.00 |
52 Week High Date | 27-Jul-2023 |
52 Week Low | 1,128.00 |
52 Week Low Date | 19-Dec-2023 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | 2,156.79135 |
Earnings | 0.785426 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
28-Mar-24 | 18:09:31 | 1,711.174 | 4,826 | Unknown* | 1,709.00 | 1,711.00 | 82.58k | O Ordinary Was reported as OTC |
28-Mar-24 | 18:08:38 | 1,710.177 | 835 | Unknown* | 1,709.00 | 1,711.00 | 14.28k | O Ordinary Was reported as OTC |
28-Mar-24 | 18:08:06 | 1,710.291 | 3,338 | Unknown* | 1,709.00 | 1,711.00 | 57.09k | O Ordinary Was reported as OTC |
28-Mar-24 | 17:55:36 | 1,694.00 | 61 | Unknown* | 1,709.00 | 1,711.00 | 1,033 | O Ordinary Was reported as OTC |
28-Mar-24 | 17:55:36 | 1,694.00 | 763 | Unknown* | 1,709.00 | 1,711.00 | 12.93k | O Ordinary Was reported as OTC |
28-Mar-24 | 17:55:01 | 1,694.00 | 781 | Unknown* | 1,709.00 | 1,711.00 | 13.23k | O Ordinary Was reported as OTC |
28-Mar-24 | 17:55:02 | 1,694.00 | 31 | Unknown* | 1,709.00 | 1,711.00 | 525.14 | O Ordinary Was reported as OTC |
28-Mar-24 | 17:55:01 | 1,694.00 | 12 | Unknown* | 1,709.00 | 1,711.00 | 203.28 | O Ordinary Was reported as OTC |
28-Mar-24 | 17:53:09 | 1,709.487 | 52,098 | Unknown* | 1,709.00 | 1,711.00 | 890.61k | O Ordinary Was reported as OTC |
28-Mar-24 | 17:53:09 | 1,709.517 | 19,000 | Unknown* | 1,709.00 | 1,711.00 | 324.81k | O Ordinary Was reported as OTC |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
18-Mar-24 | 15-Mar-24 | Transfer From | Ryan Preblick held the position of CFO & Executive Director at the time of this trade.Ryan Preblick | 0.00 | 3,920 | 229,089 | |
18-Mar-24 | 18-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,617.00 | GBX | 10,549 | 335,935 |
18-Mar-24 | 15-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,644.00 | GBX | 15,444 | 335,935 |
18-Mar-24 | 14-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,630.00 | GBX | 91,204 | 335,935 |
18-Mar-24 | 15-Mar-24 | Exercise of Option | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 555.00 | GBX | 15,444 | 335,935 |
Indivior is working to change patients lives by developing medicines to treat addiction and serious mental illnesses.